Freq.	Weight	Association
2	1.000	Zhen-Ke Wen - Zhong-Min Liu
3	0.866	Tao Ren - Yong-Jie Liang
2	0.816	Yong-Jie Liang - Zhong-Min Liu
2	0.816	Yong-Jie Liang - Zhong-Liang Guo
2	0.816	Yong-Jie Liang - Zhen-Ke Wen
2	1.000	Mei-Ling Jin - Ying-Yun Cai
2	0.816	Ying-Yun Cai - Yong-Jie Liang
2	0.816	Mei-Ling Jin - Yong-Jie Liang
2	0.707	Tao Ren - Zhong-Min Liu
2	0.707	Tao Ren - Zhong-Liang Guo
2	0.707	Tao Ren - Zhen-Ke Wen
2	0.707	Tao Ren - Ying-Yun Cai
2	0.707	Mei-Ling Jin - Tao Ren

Documents par ordre de pertinence

001930 (2008)	Tao Ren [République populaire de Chine] ; Zhen-Ke Wen ; Zhong-Min Liu ; Cheng Qian ; Yong-Jie Liang ; Mei-Ling Jin ; Ying-Yun Cai ; Lin Xu	Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
001929 (2008)	Tao Ren [République populaire de Chine] ; Ying-Yun Cai ; Yong-Jie Liang ; Mei-Ling Jin ; Zhong-Liang Guo ; Meng-Fei Tao ; Xiang He	[Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
001A57 (2007)	Tao Ren [République populaire de Chine] ; Zhen-Ke Wen ; Zhong-Min Liu ; Yong-Jie Liang ; Zhong-Liang Guo ; Lin Xu	Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis.
000D05 (2017)	Yinfeng Kang [République populaire de Chine] ; Runyu Yuan [République populaire de Chine] ; Bin Xiang [République populaire de Chine] ; Xiaqiong Zhao [République populaire de Chine] ; Pei Gao [République populaire de Chine] ; Xu Dai [République populaire de Chine] ; Ming Liao [République populaire de Chine] ; Tao Ren [République populaire de Chine]	Newcastle disease virus-induced autophagy mediates antiapoptotic signaling responses in vitro and in vivo.

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.